𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer

✍ Scribed by Martina Baur; Allan T. van Oosterom; Véronique Diéras; Michele Tubiana-Hulin; R. Charles Coombes; Thomas Hatschek; Michael Murawsky; May Klink-Alakl; Marcus Hudec; Christian Dittrich

Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
385 KB
Volume
134
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II trial of docetaxel and estram
A Phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma
✍ Amy D. Tiersten; Caron Nelsen; Susan Talbot; Linda Vahdat; Robert Fine; Andrea T 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 3 views

## Abstract ## BACKGROUND The similarity between the mechanism of action between docetaxel and estramustine generated the hypothesis of synergistic antimicrotubule effects and cytotoxicity when the two agents are combined. In addition, it has been demonstrated that estramustine binds P‐glycoprotei

Docetaxel/cisplatin as first-line chemot
Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma : A Phase II trial
✍ Martina Baur; Heinz-Roland Kienzer; Johannes Schweiger; Maria DeSantis; Erich Ge 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this Phase II study was to assess the clinical activity and toxicity of docetaxel (D) and cisplatin (P) in patients with locally advanced unresectable, metastatic, or recurrent squamous cell carcinoma of the head and neck (SCCHN). ## PATIENTS Of 34 pati